Services for Sponsors & CRO’s
Pillar Clinical Research, LLC provides expert & experienced conduct of Phase 1-4 clinical trials for both inpatient and outpatient studies. We are a multi-specialty clinical research group, with specialization in CNS indications: such as, but not limited to, schizophrenia, mood & anxiety disorders, PTSD, post-partum depression, addictions. Please see below for additional services provided to Sponsors & CRO’s.
Protocol DesignContact us for complimentary protocol feedback. From feedback on design, inclusion & exclusion criteria, budgets, to identifying recruitment challenges, allow us to help address these issues early on before study launch to reduce timeline delays mid-study.
Piloting New TechPillar Clinical Research is experienced in working with a broad range of clinical trial technologies and can help pilot technologies such as tablets, ratings software, EDC systems, subject wearables, and give feedback regarding their feasibility & practicality of use.
Resources for Pharma & Biotech StartupsPillar Clinical Research has collaborated with a myriad of CROs, industry vendors, and clinical trials based technologies. Allow us to provide our complimentary consulting services to help you begin your next project.
Richardson, TXBased in the greater Dallas area, the flagship site for Pillar has Phase 1-4 capabilities with a dedicated outpatient and a 20 bed inpatient research unit. The site also collaborates with Medical City Green Oaks Hospital for studies that require traditional psychiatric inpatient unit settings.
Based on the north side of Chicago. Pillar Chicago has outpatient, a 7 bed inpatient research unit, access to a traditional inpatient psychiatric unit, to allow for its Phase 1-4 capabilities. The site is strategically located to serve the city & suburban areas of Chicago.
Based in northwest Arkansas, Pillar’s Bentonville facility is located in one of the fastest growing areas in the country. The modern facility includes a 24 bed unit with experienced clinical research staff, capable of conducting both inpatient and outpatient Phase 1-4 clinical trials.